SURGICAL complicationsIntroduction: Incomplete anchoring of the Watchman left atrial appendage closure (LAAO) device can result in substantial device migration or device embolization (DME) requiring percutaneous or surgical retrieval. Methods: We performed a retrospective analysis of Watchman procedures (...
Over time, the body's own tissue grows over the implanted Watchman device, fully incorporating it into the heart's structure. This process, known as endothelialization, promotes long-term stability and reduces the risk of device-related complications. The Watchman device is designed to be permanent...
the entire left atrial appendage ostium; 2) the implant is stable (by gentle tug test); 3) the implant size is appropriate once deployed; and 4) the implant seals off the left atrial appendage from the left atrium (jet around the device <5 mm) and all lobes are distal to implant...
Innovative device prevents strokes – without medication - in at-risk heart patients SARASOTA, Fla., Feb. 6, 2025 /PRNewswire/ -- Sarasota Memorial Hospital has earned the #1 spot among the world's WATCHMAN providers protecting people with atrial fibrillation. This week, the Sarasota hospital's...
Although the device was found to be noninferior to warfarin in terms of preventing stroke, systemic embolism, and cardiovascular death, its use was accompanied by a higher risk of complications, mostly pericardial effusion and procedural stroke....
Implant, device, and procedural success rates were slightly higher with the Watchman FLX, which was also associated with procedures that were about 4 minutes shorter on average.“With the device redesign, we’ve improved the safety profile of the procedure substantially,” Freeman told TCTMD....
The device met all three primary endpoints in the first head-to-head comparison, but eyebrows were raised over procedural complications and high bleeding rates.
The all-cause stroke was estimated to be 0% with no reported cases of device related mortality. Only one patient died 8 months after the procedure due to pneumonia without any device related complications. In the pivotal PROTECT AF trial, an early safety hazard was identified: an increase in...
Our registry in a high-risk population treated with the innovative Watchman FLX device, showed high technical procedural success with easy implant and repositioning, no embolization, good LAA sealing and low rate of ischaemic/bleeding complications. 637 Figure...
Introduction: Watchman device implant reduces various cardio-cerebral events in patients with left atrial appendage. As there is a lack of data on device failure among the elderly undergoing this procedure, we aim to provide a perspective via the 2016-2020 National Inpatient Sample(NIS).Methods: ...